Status:
COMPLETED
Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer
Lead Sponsor:
Cell Genesys
Conditions:
Prostate Cancer
Phase:
PHASE1
PHASE2
Brief Summary
This is a multi-center, open-label, dose finding study of CV787 adenovirus in patients with hormone refractory metastatic prostate cancer. Patients will receive treatment intravenously at one of up to...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00116155
Last Update
June 28 2005
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.